Elliptic Laboratories ASA (OSL:ELABS)
Norway · Delayed Price · Currency is NOK 2.480
-0.020 (-0.80%)
Aug 4, 2026, 4:25 PM CET
Elliptic Laboratories ASA Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 74.02 | 43.06 | 76.39 | 115.58 | 178.22 | 218.15 |
Cash & Short-Term Investments | 74.02 | 43.06 | 76.39 | 115.58 | 178.22 | 218.15 |
Cash Growth | -3.59% | -43.63% | -33.91% | -35.15% | -18.30% | 118.76% |
Accounts Receivable | 82.84 | 81 | 110.94 | 60.61 | 40.5 | 29.03 |
Other Receivables | 8.92 | 8.12 | 8.13 | 9.45 | 6.91 | 17.77 |
Total Trade Receivables | 91.76 | 89.12 | 119.06 | 70.06 | 47.4 | 46.8 |
Total Current Assets | 165.78 | 132.18 | 195.45 | 185.64 | 225.62 | 264.95 |
Net Property, Plant & Equipment | 13.62 | 12.41 | 16.66 | 19.91 | 2.26 | 2.79 |
Other Intangible Assets | 70.31 | 71.45 | 66.25 | 55.63 | 47.57 | 36.56 |
Other Long-Term Assets | 4.77 | 5.62 | 82.67 | 87.03 | 73.88 | 67.05 |
Total Assets | 254.49 | 221.66 | 361.03 | 348.2 | 349.32 | 371.36 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.15 | 2 | 1.3 | 3.86 | 1.67 | 3.03 |
Short-Term Debt | - | - | 2 | 4 | 4 | 4 |
Current Portion of Leases | 5.86 | 4.8 | 6.63 | 3.99 | 2.18 | 2.61 |
Other Current Liabilities | 16.83 | 18.56 | 15.03 | 13.08 | 9.33 | 8.42 |
Total Current Liabilities | 24.84 | 25.36 | 24.96 | 24.93 | 17.18 | 18.06 |
Long-Term Debt | - | - | - | 2 | 6 | 10 |
Long-Term Leases | 8.52 | 8.31 | 10.73 | 15.87 | 0.52 | 0.53 |
Total Long-Term Liabilities | 8.52 | 8.31 | 10.73 | 17.87 | 6.52 | 10.53 |
Total Liabilities | 33.36 | 33.67 | 35.69 | 42.8 | 23.7 | 28.59 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.26 | 1.05 | 1.05 | 1.05 | 1.04 | 1.04 |
Retained Earnings | 219.87 | 186.94 | 324.29 | 304.36 | 324.58 | 341.73 |
Shareholders' Equity | 221.13 | 188 | 325.34 | 305.4 | 325.62 | 342.77 |
Total Liabilities & Equity | 254.49 | 221.66 | 361.03 | 348.2 | 349.32 | 371.36 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 14.38 | 13.11 | 19.35 | 25.86 | 12.71 | 17.14 |
Net Cash (Debt) | 59.64 | 29.95 | 57.04 | 89.72 | 165.51 | 201.01 |
Net Cash Growth | -0.49% | -47.49% | -36.43% | -45.79% | -17.66% | 162.69% |
Net Cash Per Share | 0.55 | 0.28 | 0.51 | 0.86 | 1.59 | 2.04 |
Book Value | 221.13 | 188 | 325.34 | 305.4 | 325.62 | 342.77 |
Book Value Per Share | 2.02 | 1.79 | 2.92 | 2.93 | 3.13 | 3.49 |
Tangible Book Value | 150.82 | 116.54 | 259.09 | 249.78 | 278.05 | 306.21 |
Tangible Book Value Per Share | 1.38 | 1.11 | 2.33 | 2.39 | 2.67 | 3.11 |